Enavatuzumab Human Monoclonal Antibody
Enavatuzumabis a research-grade recombinant antibody targeting CD266. Produced in mammalian cells with native-like glycosylation. Highlights Research Grade: For PK/PD studies, assay development, and ADA research. Native Glycosylation: Mammalian expression ensures native-like patterns.
Product Specifications
Product Name Alternative
FGF-inducible 14, TNFRSF12A, FN14, CD266, TweakR, Fibroblast growth factor-inducible immediate-early response protein 14, Tweak-receptor, Tumor necrosis factor receptor superfamily member 12A
UniProt
Q9NP84
Reactivity
Human
Clonality
Monoclonal
Conjugation
Unconjugated
Purification
Protein A/G purified from cell culture supernatant.
Concentration
Lot dependent
Purity
>95% purity as determined by SDS-PAGE.
Form
Liquid
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Tested Applications
ELISA, FA, FACS, In vivo
Host or Source
Human Humanized
Preservative
0.01M PBS, pH 7.4.
Isotype
IgG1-kappa
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
46141126 3x 1.0µg DNA
Tas2r103 CRISPRa sgRNA lentivector (set of three targets)(Rat)
Sign In for Pricing
View Details 
042028-ML490 100 µL
SMAD9, ID (SMAD9, MADH6, MADH9, Mothers against decapentaplegic homolog 9, Madh6, SMAD family member 9) (MaxLight 490) discontinued
Sign In for Pricing
View Details 
VD11N860 1 Each
Rabbit Anti-Porcine Fibroblast Growth Factor 2 (FGF2) Polyclonal Antibody
Sign In for Pricing
View Details